NKGen Biotech, Inc.
NKGN
$0.06
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -82.35% | 307.69% | -99.91% | -93.54% | -70.94% |
| Total Receivables | -11.54% | -7.69% | -41.46% | -36.11% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -48.16% | -66.84% | -45.83% | 88.15% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 473.74% | 478.27% | -28.88% | -21.04% | -- |
| Total Current Assets | 48.16% | 27.41% | -91.20% | -39.63% | -- |
|
|
|||||
| Total Current Assets | 48.16% | 27.41% | -91.20% | -39.63% | -- |
| Net Property, Plant & Equipment | -8.57% | -5.42% | -5.20% | -5.44% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.49% | 4.35% | 3.33% | 0.00% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -2.91% | -1.52% | -40.49% | -25.86% | -- |
|
|
|||||
| Total Accounts Payable | 18.74% | 30.35% | 69.45% | 258.89% | -- |
| Total Accrued Expenses | -45.41% | -51.56% | -53.29% | 58.56% | -- |
| Short-term Debt | 131.35% | 317.05% | 276.60% | 350.27% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | -- | 60.42% | -98.92% | -- |
| Total Finance Division Other Current Liabilities | -95.76% | -95.92% | -92.76% | 11,354.22% | -- |
| Total Other Current Liabilities | -95.76% | -95.92% | -92.76% | 11,354.22% | -- |
| Total Current Liabilities | 17.09% | 46.94% | -4.45% | 121.31% | -- |
|
|
|||||
| Total Current Liabilities | 17.09% | 46.94% | -4.45% | 121.31% | -- |
| Long-Term Debt | 9.17% | 9.17% | -27.90% | 1.63% | -- |
| Short-term Debt | 131.35% | 317.05% | 276.60% | 350.27% | -- |
| Capital Leases | -40.80% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -52.96% | -33.77% | 14.33% | 89,396.15% | -- |
| Total Liabilities | -7.28% | 14.59% | -5.76% | 155.12% | -- |
|
|
|||||
| Common Stock & APIC | 14.71% | 12.29% | 7.78% | 50.12% | -- |
| Retained Earnings | -14.06% | -27.32% | -9.64% | -92.56% | -- |
| Treasury Stock & Other | 98.25% | 99.01% | -- | -- | -- |
| Total Common Equity | 8.58% | -19.11% | -15.78% | -464.24% | -3,622.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.58% | -19.11% | -15.78% | -464.24% | -3,622.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.58% | -19.11% | -15.78% | -464.24% | -3,622.39% |
|
|
|||||